Related Experiment Video
Updated: Feb 24, 2026

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage
Chun-Che Tseng1, Bailing Jia1,2, Robert Barndt1
1Lombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Abstract:
The type 2 transmembrane serine protease matriptase is involved in many pathophysiological processes probably via its enzymatic activity, which depends on the dynamic relationship between zymogen activation and protease inhibition. Matriptase shedding can prolong the life of enzymatically active matriptase and increase accessibility to substrates. We show here that matriptase shedding occurs via a de novo proteolytic cleavage at sites located between the SEA domain and the CUB domain. Point or combined mutations at the four positively charged amino acid residues in the region following the SEA domain allowed Arg-186 to be identified as the primary cleavage site responsible for matriptase shedding. Kinetic studies further demonstrate that matriptase shedding is temporally coupled with matriptase zymogen activation. The onset of matriptase shedding lags one minute behind matriptase zymogen activation. Studies with active site triad Ser-805 point mutated matriptase, which no longer undergoes zymogen activation or shedding, further suggests that matriptase shedding depends on matriptase zymogen activation, and that matriptase proteolytic activity may be involved in its own shedding. Our studies uncover an autonomous mechanism coupling matriptase zymogen activation, proteolytic activity, and shedding such that a proportion of newly generated active matriptase escapes HAI-1-mediated rapid inhibition by shedding into the extracellular milieu.
Insights
Matriptase shedding, a process prolonging active protease function, is triggered by de novo cleavage at Arg-186. This shedding is coupled to zymogen activation, revealing an autonomous mechanism for active matriptase release.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Matriptase, a type 2 transmembrane serine protease, participates in various pathophysiological processes.
- Its enzymatic activity is regulated by zymogen activation and protease inhibition.
- Matriptase shedding can extend the availability of active protease and substrate access.
Purpose of the Study:
- To investigate the mechanism and regulation of matriptase shedding.
- To identify the specific cleavage site responsible for matriptase shedding.
- To elucidate the relationship between matriptase zymogen activation, proteolytic activity, and shedding.
Main Methods:
- Site-directed mutagenesis of positively charged residues in the SEA-CUB domain region.
- Kinetic analysis of matriptase zymogen activation and shedding.
- Functional studies using active site mutants (Ser-805).
Main Results:
- Matriptase shedding is mediated by de novo proteolytic cleavage between the SEA and CUB domains.
- Arginine-186 (Arg-186) was identified as the primary cleavage site for matriptase shedding.
- Matriptase shedding is temporally coupled to and dependent on zymogen activation, occurring approximately one minute after activation.
- Proteolytic activity of matriptase may contribute to its own shedding.
Conclusions:
- Matriptase shedding is an autonomous mechanism linked to zymogen activation and proteolytic activity.
- This shedding allows active matriptase to escape rapid inhibition by HAI-1, releasing it into the extracellular environment.
- The findings provide new insights into the regulation of matriptase activity and its role in disease.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Caspases
Clot Retraction and Fibrinolysis
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...

